Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

JOURNAL ARTICLE published 10 October 2019 in Journal of Clinical Oncology

Authors: Jonathan E. Rosenberg | Peter H. O’Donnell | Arjun V. Balar | Bradley A. McGregor | Elisabeth I. Heath | Evan Y. Yu | Matthew D. Galsky | Noah M. Hahn | Elaina M. Gartner | Juan M. Pinelli | Shang-Ying Liang | Amal Melhem-Bertrandt | Daniel P. Petrylak